Table 1 The distribution of different pathological entities within the benign and malignant lesions

Benign

Hamartoma

1/39

2.6%

Duct ectasia

1/39

2.6%

Fibroadenoma

9/39

23%

Intramammary LN

2/39

5.1%

fibrocystic changes

7/39

17.9 %

Adenosis

8/39

20.5%

Benign postoperative sequel

6/39

15.4%

Abscess

1/39

2.6%

Granulomatous mastitis

1/39

2.6%

Cluster cysts

1/39

2.6%

Radial scars

2/39

5.1%

Malignant

IDC

13/18

(72%)

DCIS and IDC

3/18

(17%)

ILC

2/18

(11%)